Publication & Citation Trends
Most Cited Works
Publications
31 total
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma PDF
Cited by 3
OpenAlex
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration PDF
Cited by 6
OpenAlex
Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors PDF
Cited by 4
OpenAlex
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo</i>–<i>In Vitro</i>–<i>In Silico</i> Approach PDF
Cited by 17
OpenAlex
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections PDF
Cited by 14
OpenAlex
Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
Cited by 13
OpenAlex
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model PDF
Cited by 7
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(7)
Colorectal Cancer Treatments and Studies
(7)
Melanoma and MAPK Pathways
(7)
Monoclonal and Polyclonal Antibodies Research
(6)
HER2/EGFR in Cancer Research
(3)
Frequent Co-Authors
Affiliations
University of North Carolina at Chapel Hill
University of North Carolina Health Care
Pfizer (United States)
University of California, San Diego
University of Montana